Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
9
Frequently Asked Questions
What is Market Cap of Forte Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Forte Biosciences Inc market cap is $21.95M.
What is the 52-week high for Forte Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Forte Biosciences Inc 52 week high is $1.06 as of June 05, 2024.
What is the 52-week low for Forte Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Forte Biosciences Inc 52 week low is $0.38 as of June 05, 2024.
What is Forte Biosciences Inc stock price today?
Forte Biosciences Inc stock price today is $0.6024.
What was Forte Biosciences Inc stock price yesterday?
Forte Biosciences Inc stock price yesterday was $0.581.
What is the PE ratio of Forte Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Forte Biosciences Inc’s P/E ratio is -0.60.
What is the Price-to-Book ratio of Forte Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Forte Biosciences Inc P/B ratio is 0.7643.
What is Forte Biosciences Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Forte Biosciences Inc's EBITDA is -0.05.
What is the 50-day moving average of Forte Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Forte Biosciences Inc 50-day moving average is $0.6876.
How many employess does Forte Biosciences Inc has?